Gram-negative bacterial ghosts produced by controlled expression of th
e plasmid-encoded lysis gene E offers a promising approach in non-livi
ng vaccine technology. Bacterial cell wall complex and hence the antig
enic determinants of the living cells are not affected by denaturation
due to cell killing. However, the endotoxin content of the Gram-negat
ive cell wall has been discussed as a potential problem for this kind
of whole cell or envelope vaccines. Here we show that bacterial ghosts
prepared from Escherichia coli 026:B6 and Salmonella typhimurium C5 i
nduce dose-dependent antibody responses against bacterial cells or the
ir corresponding lipopolysaccharides (LPS) in doses 25 ng kg(-1) when
administered intravenously to rabbits in a standard immunization proto
col. No differences between the immune responses of the rabbits were o
bserved when comparing equivalent doses of bacterial ghosts and antibi
otic-treated whole cells. The results indicate that the bacterial ghos
ts exhibit all the antigenic properties of the living cells. No signif
icant fever responses in rabbits have been recorded in doses of <250 n
g kg(-1) E. coli 026:B6 ghosts and up to doses of 250 ng kg-1 S. typhi
murium C5 ghosts when applying test methods recommended by the US phar
macopoeia. These findings correlate with cell culture experiments wher
e doses 100 ng ml(-1) of bacterial ghosts were needed for the release
of tumour necrosis factor alpha (TNF alpha) and prostaglandin E(2) (PG
E(2)) from RAW mouse macrophage cultures. Free LPS of Salmonella abort
us equi commonly used as a LPS-standard, however, stimulated TNF alpha
and PGE(2) synthesis of RAW cells in doses of 1 ng ml(-1). The endoto
xic activity of our bacterial preparations analysed by a standard limu
lus amoebocyte lysate and 2-keto-3-deoxyoctonate assay correlated with
the capacity to stimulate the release of PGE(2) and TNF alpha in RAW
mouse macrophage cultures and the endotoxic responses in rabbits. It c
an be concluded that these in vitro systems can be used as easy predic
tive test systems for preparations of bacterial vaccines, particularly
for bacterial ghosts. Copyright (C) 1997 Elsevier Science Ltd.